Maxigen Biotech Inc (TPE:1783) Stock Price, Trades & News

Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is mainly engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products. It generates the majority of the revenue from the Biomedical products segment.

Financial Strength

10/10

Name	Current	Vs Industry
Cash-To-Debt	32027.7
Equity-to-Asset	0.87
Interest Coverage	No Debt
Piotroski F-Score	7/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	11.73	Distress Grey Safe
Beneish M-Score	-3	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

5/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	7.8
	3-Year EBITDA Growth Rate	16.9
	3-Year EPS without NRI Growth Rate	28.2
	3-Year FCF Growth Rate	34.9
	3-Year Book Growth Rate	6.3

Momentum Rank

5/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	55.53
	9-Day RSI	45.33
	14-Day RSI	41.82
	3-1 Month Momentum %	-7.45
	6-1 Month Momentum %	11.32
	12-1 Month Momentum %	8.88

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	4.03
	Quick Ratio	3.67
	Cash Ratio	3.11
	Days Inventory	142.2
	Days Sales Outstanding	47.63
	Days Payable	57.81

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	2.46
	Dividend Payout Ratio	0.45
	3-Year Dividend Growth Rate	16.4
	Forward Dividend Yield %	2.46
	5-Year Yield-on-Cost %	2.46
	3-Year Average Share Buyback Ratio	-0.1
	Shareholder Yield %	1.71

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	71.01
	Operating Margin %	28.56
	Net Margin %	27.94
	FCF Margin %	39.15
	ROE %	14.08
	ROA %	12.4
	ROIC %	19.11
	3-Year ROIIC %	49.65
	ROC (Joel Greenblatt) %	44.41
	ROCE %	14.38
	Years of Profitability over Past 10-Year	8

GF Value Rank

8/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	19.42
	PE Ratio without NRI	18.38
	Shiller PE Ratio	45.71
	Price-to-Owner-Earnings	13.96
	PEG Ratio	1.22
	PS Ratio	5.42
	PB Ratio	2.67
	Price-to-Tangible-Book	2.67
	Price-to-Free-Cash-Flow	13.78
	Price-to-Operating-Cash-Flow	12.33
	EV-to-EBIT	15.61
	EV-to-EBITDA	13.69
	EV-to-Revenue	4.46
	EV-to-FCF	10.78
	Price-to-GF-Value	0.82
	Price-to-Projected-FCF	1.13
	Price-to-Median-PS-Value	0.98
	Price-to-Peter-Lynch-Fair-Value	1.39
	Price-to-Graham-Number	1.48
	Price-to-Net-Current-Asset-Value	5.89
	Price-to-Net-Cash	8.48
	Earnings Yield (Greenblatt) %	6.41
	FCF Yield %	7.24
	Forward Rate of Return (Yacktman) %	18.2

Financials

Annual Quarterly TTM

TPE:1783's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016

Maxigen Biotech Inc Executives

Details

GF Value: NT$50.49

TPE:1783

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 11 Good signs with 1783. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil NT$)	680.651
	EPS (TTM) (NT$)	2.12
	Beta	-0.35
	3-Year Sharpe Ratio	0.19
	3-Year Sortino Ratio	0.3
	Volatility %	26.34
	14-Day RSI	41.82
	14-Day ATR (NT$)	2.003605
	20-Day SMA (NT$)	42.815
	12-1 Month Momentum %	8.88
	52-Week Range (NT$)	35.55 - 55
	Shares Outstanding (Mil)	89.16

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	7
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Maxigen Biotech Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Maxigen Biotech Inc Stock Events

Financials Calendars

	Event	Date	Price (NT$)
No Event Data

Maxigen Biotech Inc Frequently Asked Questions

What is Maxigen Biotech Inc(TPE:1783)'s stock price today?

The current price of TPE:1783 is NT$41.20. The 52 week high of TPE:1783 is NT$55.00 and 52 week low is NT$35.55.

When is next earnings date of Maxigen Biotech Inc(TPE:1783)?

The next earnings date of Maxigen Biotech Inc(TPE:1783) is .

Does Maxigen Biotech Inc(TPE:1783) pay dividends? If so, how much?

The Dividend Yield % of Maxigen Biotech Inc(TPE:1783) is 2.46% (As of Today), Highest Dividend Payout Ratio of Maxigen Biotech Inc(TPE:1783) was 0.86. The lowest was 0.19. And the median was 0.52. The Forward Dividend Yield % of Maxigen Biotech Inc(TPE:1783) is 2.46%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
No Press Release

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.